|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Biochemistry and Biophysics |
Department of Pathology [L.L.C.], NMR Center and Division of Neuroradiology, Department of Radiology [A.R.C., R.G.G.], Massachusetts General Hospital, Boston, MA 02129; Department of Pathology [D.C.A.], Department of Radiology [A.A.T.], Department of Neurosurgery [P.M.B.], Children's Hospital, Boston, MA 02115; Department of Pathology [D.C.A.], Department of Neurosurgery [P.M.B.], Brigham and Women's Hospital; and Harvard Medical School, Boston, MA 02115
2 Address correspondence and reprint requests to Leo L. Cheng, Pathology Research, MGH CNY-7, 149 13th St., Charlestown, MA 02129.
Abstract
Microheterogeneity is a routinely observed neuropathologic characteristic in brain tumor pathology. Although microheterogeneity is readily documented by routine histologic techniques, these techniques only measure tumor status at the time of biopsy or surgery and do not indicate likely tumor progression. A biochemical screening technique calibrated against pathologic standards would greatly assist in predicting tumor progression from its biological activity. Here we demonstrate for the first time that proton magnetic resonance spectroscopy (1H MRS) with high-resolution magic-angle spinning (HRMAS), a technique introduced in 1997, can preserve tissue histopathologic features while producing well-resolved spectra of cellular metabolites in the identical intact tissue specimens. Observed biochemical alterations and tumor histopathologic characteristics can thus be correlated for the same surgical specimen, obviating the problems caused by tumor microheterogeneity. We analyzed multiple specimens of a single human glioblastoma multiforme surgically removed from a 44-year-old patient. Each specimen was first measured with HRMAS 1H MRS to determine tumor metabolites, then evaluated by quantitative histopathology. The concentrations of lactate and mobile lipids measured with HRMAS linearly reflected the percentage of tumor necrosis. Moreover, metabolic ratios of phosphorylcholine to choline correlated linearly with the percentage of the highly cellular malignant glioma. The quantification of tumor metabolic changes with HRMAS 1H MRS, in conjunction with subsequent histopathology of the same tumor specimen, has the potential to further our knowledge of the biochemistry of tumor heterogeneity during development, and thus ultimately to improve our accuracy in diagnosing, characterizing, and evaluating tumor progression.
References
Barker, F.G., Davis, R.L., Chang, S.M., and Prados, M.D. (1996) Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77,1161 -1166.[CrossRef][ISI][Medline]
Barker, P.B., Soher, B.J., Blackband, S.J., Chatham, J.G., Mathews, V.P., and Bryan, R.N. (1993) Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed. 6,89 -94.[ISI][Medline]
Carpinelli, G., Carapella, C.M., Palombi, L., Raus, L., Caroli, F., and Podo, F. (1996) Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. Anticancer Res. 16,1559 -1563.[Medline]
Cheng, L.L., Lean, C.L., Bogdanova, A., Wright, J.C., Jr., Ackerman, J.L., Brady, T.J., and Garrido, L. (1996) Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn. Reson. Med. 36,653 -658.[Medline]
Cheng, L.L., Ma, M.J., Becerra, L., Ptak, T., Tracey, I., Lackner,
A., and Gonzalez, R.G. (1997) Quantitative neuropathology by high
resolution magic angle spinning proton magnetic resonance spectroscopy.
Proc. Natl. Acad. Sci. U.S.A.
94,6408
-6413.
Cheng, L.L., Chang, I.W., Louis, D.N., and Gonzalez, R.G.
(1998a) Correlation of high resolution magic angle spinning
proton magnetic resonance spectroscopy with histopathology of intact human
brain tumor specimens. Cancer Res.
58,1825
-1832.
Cheng, L.L., Chang, I.W., Smith, B.L., and Gonzalez, R.G. (1998b) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J. Magn. Reson. 135,194 -202.[CrossRef][ISI][Medline]
Coons, S.W., and Johnson, P.C. (1993) Regional heterogeneity in the DNA content of human gliomas. Cancer 72,3052 -3060.[CrossRef][ISI][Medline]
Dalrymple, S.J., Herath, J.F., Ritland, S.R., Moertel, C.A., and Jenkins, R.B. (1995) Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas. J. Neurosurg. 83,316 -323.[Medline]
Daumas-Duport, C., Scheithauer, B.W., O'Fallon, J., and Kelly, P.J. (1988) Grading of astrocytomas: A simple and reproducible method. Cancer 62,2152 -2165.[CrossRef][ISI][Medline]
Florian, C.L., Preece, N.E., Bhakoo, K.K., Williams, S.R., and Noble, M. (1995) Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed. 8,253 -264.[Medline]
Garrod, S., Humpfer, E., Spraul, M., Connor, S.C., Polley, S., Connelly, J., Lindon, J.C., Nicholson, J.K., and Holmes, E. (1999) High-resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn. Reson. Med. 41,1108 -1118.[CrossRef][ISI][Medline]
Gotsis, E.D., Fountas, K., Kapsalaki, E., Toulas, P., Peristeris, G., and Papadakis, N. (1996) In vivo proton MR spectroscopy: The diagnostic possibilities of lipid resonances in brain tumors. Anticancer Res. 16,1565 -1567.[Medline]
Harada, M., Tanouchi, M., Nishitani, H., Miyoshi, H., Bandou, K., and Kannuki, S. (1995) Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy. Jpn. J. Cancer Res. 86,329 -332.[Medline]
Hsu, D.W., Louis, D.N., Efird, J.T., and Hedley-Whyte, E.T. (1997) Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas. J. Neuropathol. Exp. Neurol. 56,857 -865.[Medline]
Hyman, B.T., Gomez-Isla, T., and Irizarry, M.C. (1998) Stereology: A practical primer for neuropathology. J. Neuropathol. Exp. Neurol. 57,305 -310.[ISI][Medline]
Karkavelas, G., Mavropoulou, S., Fountzilas, G., Christoforidou, V., Karavelis, A., Foroglou, G., and Papadimitriou, C. (1995) Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme. Anticancer Res. 15,531 -536.[Medline]
Kinoshita, Y., Kajiwara, H., Yokota, A., and Koga, Y. (1994) Proton magnetic resonance spectroscopy of brain tumors: An in vitro study. Neurosurgery 35,606 -614.[Medline]
Kuesel, A.C., Sutherland, G.R., Halliday, W., and Smith, I.C. (1994a) 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed. 7, 149-155.[Medline]
Kuesel, A.C., Donnelly, S.M., Halliday, W., Sutherland, G.R., and Smith, I.C. (1994b) Mobile lipids and metabolic heterogeneity of brain tumours as detectable by ex vivo 1H MR spectroscopy. NMR Biomed. 7,172 -180.[Medline]
Kuesel, A.C., Briere, K.M., Halliday, W.C., Sutherland, G.R., Donnelly, S.M., and Smith, I.C.P. (1996) Mobile lipid accumulation in necrotic tissue of high grade astrocytomas. Anticancer Res. 16,1485 -1489.[Medline]
Kugel, H., Heindel, W., Ernestus, R.I., Bunke, J., du Mesnil, R.,
and Friedmann, G. (1992) Human brain tumors: Spectral patterns
detected with localized H-1 MR spectroscopy. Radiology
183,701
-709.
Landry, C.F., Verity, M.A., Cherman, L., Kashima, T., Black, K.,
Yates, A., and Campagnoni, A.T. (1997) Expression of
oligodendrocytic mRNAs in glial tumors: Changes associated with tumor grade
and extent of neoplastic infiltration. Cancer Res.
57,4098
-4104.
Leenstra, S., Troost, D., Das, P.K., Claessen, N., Becker, A.E., and Bosch, D.A. (1993) Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer 72,3061 -3067.[CrossRef][ISI][Medline]
Levin, V.A., Leibel, S.A., and Gutin, P.H. (1997) Neoplasms of the central nervous system. In: DeVita, V.T., Jr., Hellman, S., and Rosenberg, S.A. (Eds.), Cancer Principles & Practice of Oncology, Vol. 2. Fifth edition. Philadelphia: Lippincott-Raven. pp.2022 -2081.
McBride, D.Q., Miller, B.L., Nikas, D.L., Buchthal, S., Chang, L., Chiang, F., and Booth, R.A. (1995) Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg. Neurol. 44,137 -144.[CrossRef][ISI][Medline]
Middleton, D.A., Bradley, D.P., Connor, S.C., Mullins, P.G., and Reid, D.G. (1998) The effect of sample freezing on proton magic-angle spinning NMR spectra of biological tissue. Magn. Reson. Med. 40,166 -169.[Medline]
Miller, B.L., Chang, L., Booth, R., Ernst, T., Cornford, M., Nikas, D., McBride, D., and Jenden, D.J. (1996) In vivo 1H MRS choline: Correlation with in vitro chemistry/histology. Life Sci. 58,1929 -1935.[CrossRef][ISI][Medline]
Millis, K.K., Maas, W.E., Cory, D.G., and Singer, S. (1997) Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue. Magn. Reson. Med. 38,399 -403.[ISI][Medline]
Moka, D., Vorreuther, R., Schicha, H., Spraul, M., Humpfer, E., Lipinski, M., Foxall, P., Nicholson, J., and Lindon, J. (1997) Magic angle spinning proton nuclear magnetic resonance spectroscopic analysis of intact kidney tissue samples. Anal. Commun. 34,107 -109.[CrossRef]
Moka, D., Vorreuther, R., Schicha, H., Spraul, M., Humpfer, E., Lipinski, M., Foxall, P.J., Nicholson, J.K., and Lindon, J.C. (1998) Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 17,125 -132.[CrossRef][Medline]
Montine, T.J., Vandersteenhoven, J.J., Aguzzi, A., Boyko, O.B., Dodge, R.K., Kerns, B.-J., and Burger, P.C. (1994) Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 34,674 -679.[Medline]
Mountford, C., Lean, C.L., Mackinnon, W., and Russell, P. (1993) The use of proton MR in cancer pathology. In: Webb, G. (Ed.), Annual Report on NMR Spectroscopy, Vol.27 . London: Academic Press. pp.173 -215.
Peeling, J., and Sutherland, G. (1992) High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn. Reson. Med. 24,123 -136.[Medline]
Preul, M.C., Caramanos, Z., Collins, D.L., Villemure, J.-G., Leblanc, R., Olivier, A., Pokrupa, R., and Arnold, D.L. (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat. Med. 2, 323-325.[CrossRef][ISI][Medline]
Ruiz-Cabello, J., and Cohen, J.S. (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 5,226 -233.[ISI][Medline]
Rutter, A., Hugenholtz, H., Saunders, J.K., and Smith, I.C. (1995) Classification of brain tumors by ex vivo 1H NMR spectroscopy. J. Neurochem. 64,1655 -1661.[Medline]
Shimizu, H., Kumabe, T., Tominaga, T., Kayama, T., Hara, K., Ono, Y., Sato, K., Arai, N., Fujiwara, S., and Yoshimoto, T. (1996) Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am. J. Neuroradiol. 17,737 -747.[Abstract]
Sijens, P.E., van Dijk, P., and Oudkerk, M. (1994) Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magn. Reson. Med. 32,549 -555.[Medline]
Somorjai, R.L., Dolenko, B., Nikulin, A.K., Pizzi, N., Scarth, G., Zhilkin, P., Halliday, W., Fewer, D., Hill, N., Ross, I., West, M., Smith, I.C., Donnelly, S.M., Kuesel, A.C., and Briere, K.M. (1996) Classification of 1H MR spectra of human brain neoplasms: The influence of preprocessing and computerized consensus diagnosis on classification accuracy. J. Magn. Reson. Imaging 6, 437-444.[ISI][Medline]
Speck, O., Thiel, T., and Hennig, J. (1996) Grading and therapy monitoring of astrocytomas with 1H spectroscopy. Anticancer Res. 16,1581 -1585.[Medline]
Sung, C.C., Pearl, D.K., Coons, S.W., Scheithauer, B.W., Johnson, P.C., and Yates, A.J. (1994) Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 74,3010 -3022.[CrossRef][Medline]
Sutton, L.N., Wang, Z., Gusnard, D., Lange, B., Perilongo, G., Bogdan, A.R., Detre, J.A., Rorke, L., and Zimmerman, R.A. (1992) Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31,195 -202.[Medline]
Sutton, L.N., Wehrli, S.L., Gennarelli, L., Wang, Z., Zimmerman, R., Bonner, K., and Rorke, L.B. (1994) High-resolution 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J. Neurosurg. 81,443 -448.[Medline]
Sze, D.Y., and Jardetzky, O. (1990) Determination of metabolite and nucleotide concentrations in proliferating lymphocytes by 1H-NMR of acid extracts. Biochim. Biophys. Acta 1054,181 -197.[Medline]
Tomlins, A., Foxall, P., Lindon, J., Lynch, M., Spraul, M., Everett, J., and Nicholson, J. (1998) High resolution magic angle spinning 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumor tissues. Anal. Commun. 35,113 -115.
Tugnoli, V., Tosi, M.R., Barbarella, G., Bertoluzza, A., Ricci, R., and Trevisan, C. (1996) In vivo 1H MRS and in vitro multinuclear MR study of human brain tumors. Anticancer Res. 16,2891 -2899.[Medline]
Usenius, J.P., Kauppinen, R.A., Vainio, P.A., Hernesniemi, J.A., Vapalahti, M.P., Paljarvi, L.A., and Soimakallio, S. (1994a) Quantitative metabolite patterns of human brain tumors: Detection by 1H NMR spectroscopy in vivo and in vitro. J. Comput. Assist. Tomogr. 18,705 -713.[Medline]
Usenius, J.P., Vainio, P., Hernesniemi, J., and Kauppinen, R.A. (1994b) Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J. Neurochem. 63,1538 -1543.[Medline]
Wang,Y., and Li, S.-J. (1998) Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn. Reson. Med. 39,28 -33.[ISI][Medline]
Wang, Z., Sutton, L.N., Cnaan, A., Haselgrove, J.C., Rorke, L.B., Zhao, H., Bilaniuk, L.T., and Zimmerman, R.A. (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am. J. Neuroradiol. 16,1821 -1833.[Abstract]
Weber, R.G., Sommer, C., Albert, F.K., Kiessling, M., and Cremer, T. (1996) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab. Invest. 74,108 -119.[ISI][Medline]
Weybright, P., Millis, K., Campbell, N., Cory, D.G., and Singer, S. (1998) Gradient, high-resolution, magic angle spinning 1H nuclear magnetic resonance spectroscopy of intact cells. Magn. Reson. Med. 39,337 -345.[ISI][Medline]
Yates, A.J. (1992) An overview of principles for classifying brain tumors. Mol. Chem. Neuropathol. 17,103 -120.[Medline]
This article has been cited by other articles:
|
|
 |
|
  A. A. Tzika, M. K. Zarifi, L. Goumnerova, L. G. Astrakas, D. Zurakowski, T. Young-Poussaint, D. C. Anthony, R. M. Scott, and P. McL. Black Neuroimaging in Pediatric Brain Tumors: Gd-DTPA-enhanced, Hemodynamic, and Diffusion MR Imaging Compared with MR Spectroscopic Imaging AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 322 - 333. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
